CAS 544707-19-9

JNJ 10181457

Produit contrôlé

CAS : 544707-19-9

Applications JNJ 10181457 is a selective non-imidazole histamine H3 receptor antagonist that normalizes acetylcholine neurotransmission.
References Galici, R. et al.: Neuropharmacol., 56, 1131 (2009); Bonaventure, P. et al.: Biochem. Pharmacol., 73, 1084 (2007)

Formule : C₂₀H₂₈N₂O·2ClH

Couleur et forme : Neat

Masse moléculaire : 385.371

Ref: TR-J211315

JNJ 10181457

CAS : 544707-19-9

JNJ 10181457 is a drug that modulates the immune system and may be used as an immunomodulator to treat inflammatory conditions. It has been shown to have a number of effects on the immune system, including modulation of the immune response, induction of antigen-specific T-cell responses, and activation of macrophages. JNJ 10181457 has also been shown to suppress tumor growth in animal models by inducing apoptosis and inhibiting angiogenesis. This drug may be useful for treating cancer or autoimmune diseases because it blocks inflammation, which is involved in the development of these conditions.

Formule : C₂₀H₃₀Cl₂N₂O

Degré de pureté : Min. 95%

Masse moléculaire : 385.4 g/mol

Ref: 3D-UWA70719

JNJ 10181457 dihydrochloride

CAS : 544707-19-9

JNJ 10181457 dihydrochloride is a Histamine H3 receptor antagonist.

Formule : C₂₀H₂₈N₂O

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 312.45

Ref: TM-T22878